Target intelligence / Profile preview

Carmustine on DNA, RNA, and proteins

Molecular classification
Other
01

Overview

Carmustine is a nitrosourea alkylating agent used in chemotherapy for multiple cancers, notably brain tumors and hematological malignancies. It exerts cytotoxic effects primarily by forming covalent cross-links within DNA, thereby inhibiting DNA replication and transcription, and can also alkylate RNA and proteins. This multifaceted alkylation leads to cell cycle arrest, apoptosis, and cell death in rapidly dividing cells. Carmustine can also carbamoylate proteins, affecting their function, with glutathione reductase among notable protein targets. Its broad molecular reactivity underlies both its antitumor activity and a range of toxicities.

Other names
Carmustine target(s): DNA, RNA, and proteins
02

Mechanism of action

Alkylation and cross-linking of DNA and RNA, leading to inhibition of replication, transcription, and translation. Protein carbamoylation (notably enzymes such as glutathione reductase).

03

Biological functions

Cell deathCell cycleApoptosisInhibition of DNA synthesisInhibition of RNA transcriptionInhibition of protein synthesis
04

Disease associations

Cancer (brain tumors, multiple myeloma, lymphomas)
05

Safety considerations

Bone marrow suppressionIncreased risk of infectionBleeding/bruisingPulmonary toxicityHepatic and renal toxicitySecondary malignancies (carcinogenicity)
06

Interacting drugs

Carmustine (BCNU)

1 more in the full profile.

Beyond the preview

Go deeper on Carmustine on DNA, RNA, and proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carmustine on DNA, RNA, and proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call